Skip to main content

Table 1 Relationship between CD44v9 expression and clinicopathological characteristics in invasive UC patients treated with CDDP-based chemotherapy against recurrence and/or metastasis after surgery

From: Variant isoforms of CD44 involves acquisition of chemoresistance to cisplatin and has potential as a novel indicator for identifying a cisplatin-resistant population in urothelial cancer

 

CD44v9

 
 

Negative

Positive

p-value

Age

  < 68

5

29

0.650

  ≥ 68

8

35

Gender

 male

9

45

0.938

 female

4

19

Tumor location

 upper tract

9

49

0.576

 bladder

4

15

Tumor grade

 G1/2

3

4

0.054

 G3

10

60

Pathological T stage

 pT2

5

7

0.013

 pT3/4

8

57

Lymphovascular invasion

 negative

5

15

0.260

 positive

8

49

Lymph node metastasis

 pNx or pN0

10

54

0.722

 pN1, 2

3

10

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us